TB-500 Chemistry: Thymosin Beta-4 Fragment
A bench-level reference sheet on TB-500, the synthetic actin-binding fragment of thymosin beta-4: where it sits in peptide chemistry, how the short sequence is assembled, and what to read off it before keeping one as a reference standard.
Sequence and Structure
TB-500 is the laboratory shorthand for a synthetic peptide that reproduces the central actin-binding region of thymosin beta-4. Where the parent protein runs 43 residues, the fragment supplied as a reference standard reproduces the short seven-residue motif most associated with actin binding, which makes TB-500 a compact, single-chain linear peptide rather than a full-length protein. That brevity is the defining structural fact for a research chemist: a short, unmodified sequence assembles cleanly and characterizes predictably.
The fragment carries no disulfide bridges and no cyclization, so there is little conformational ambiguity to resolve on the bench. Reading the sequence tells you most of what you need before any material is handled. The presence of an N-terminal acetyl group and a free or amidated C-terminus is the kind of detail worth confirming from a given standard's documentation, since those endgroups change the measured mass and can shift retention on a reversed-phase column.
Origin and Family
TB-500 belongs to the beta-thymosin lineage by way of thymosin beta-4, the widely studied actin-sequestering peptide from which the fragment is drawn. Thymosin beta-4 itself is a small, intrinsically disordered protein, and the seven-residue actin-binding stretch reproduced in TB-500 is the part of that sequence most often isolated for focused study. Treating the fragment as a defined relative of its parent, rather than an unrelated molecule, makes its chemistry easier to anticipate.
Within a research catalog, TB-500 is grouped in the BPC / TB Series alongside other short repair-and-recovery research peptides. That shared shelf is a matter of category and handling rather than identical chemistry, but the grouping is useful because these short linear sequences respond to the same synthetic and analytical methods. For a broader view of how short peptides are assembled, the Fmoc and Boc synthesis overview is a useful companion to this sheet.
Synthesis
A seven-residue sequence is comfortably within reach of Fmoc solid-phase peptide synthesis, the standard route for research-grade material in this class. The chain is built one residue at a time on resin using base-labile Fmoc protection, with mild acidic cleavage at the end to release the peptide and remove side-chain protecting groups. At this length the build is short enough that on-resin aggregation, the problem that complicates longer sequences, is rarely the limiting factor.
Coupling efficiency still governs final purity. Even on a short peptide, incomplete couplings generate deletion sequences that have to be resolved downstream, so research-grade routes use optimized activators and clean, well-loaded resin to keep each step complete. Any N-terminal acetylation is performed on-resin before cleavage. After cleavage the crude peptide is purified by preparative reversed-phase chromatography and then lyophilized to the dry powder that is supplied as a reference standard.
Characterization (Method)
Identity and purity for TB-500 are established with the same two complementary tools used across the reference catalog. Reversed-phase HPLC reports the purity figure, the percentage of total peak area attributable to the target peptide, and it separates the main product from closely related deletion and truncation sequences. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the sequence, including any acetyl endgroup.
Reading these together matters. An HPLC purity figure describes how much of the sample is the intended peptide relative to other UV-absorbing species, while the mass result confirms the main peak is the right molecule rather than a same-length impurity. Both describe the chemistry of the sequence and are interpreted together rather than in isolation. The same method logic is covered in more depth in the HPLC purity overview. Supporting documentation is available on request.
Stability and Storage
As a lyophilized powder, TB-500 is comparatively stable when kept cold, dry, and out of light. Long-term storage of the dry solid is typically at freezer temperatures, with the container protected from moisture so the hygroscopic powder does not pick up water on opening. Allowing a sealed vial to reach room temperature before it is opened helps avoid condensation on the cold contents.
Once reconstituted, the working solution is far less forgiving. Peptides in solution are subject to hydrolysis, oxidation, and adsorption to surfaces, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized. These are general handling principles for research peptides rather than claims about any one preparation, and the documentation for a given standard should be the reference of record for its own conditions.
What TB-500 Is Studied For (Chemistry Only)
In a research-chemistry context, TB-500 is of interest as a tractable model of an actin-binding peptide motif. Because it isolates a short, well defined stretch of thymosin beta-4, it lets chemists study how a single binding region behaves on its own, separate from the full-length disordered protein, and how endgroup chemistry and sequence length affect its synthesis, solubility, and chromatographic behavior. It also serves as a well characterized reference point when validating synthesis and analytical methods on related short peptides.
That framing is deliberately limited to the bench. These materials are reference standards for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. The value of TB-500 to a research chemist is as a chemistry subject, a short and well understood sequence whose behavior under synthesis, analysis, and storage is worth knowing in detail.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
TB-500 chemistry, answered
What is TB-500 in chemical terms?
TB-500 is a synthetic peptide corresponding to the seven-residue actin-binding region of thymosin beta-4. It is a short linear sequence assembled by solid-phase synthesis, supplied as a lyophilized reference standard for laboratory research only.
How is TB-500 different from thymosin beta-4?
Thymosin beta-4 is the full 43-residue parent peptide. TB-500 reproduces only its central actin-binding fragment, so it is a much shorter sequence that is simpler to synthesize and to characterize while retaining the motif of interest to research chemists.
How is the identity and purity of TB-500 confirmed?
Identity and purity are confirmed using reversed-phase HPLC, which reports the purity figure and separates closely related sequences, together with mass spectrometry, which matches the measured mass to the expected mass for the sequence. Documentation is available on request.
How should TB-500 be stored?
As a lyophilized powder, TB-500 is kept cold, dry, and out of light, with long-term storage at freezer temperatures and the container protected from moisture. Once reconstituted, it is held cold and used within a short window with freeze-thaw cycles minimized.